NCT07646730 Wearable Device-Based Early Warning of Postoperative Complications in Thoracic Surgery
| NCT ID | NCT07646730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tongji Hospital |
| Condition | Postoperative Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2025-12-16 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After thoracic surgery, some patients may develop complications such as lung infection, abnormal heart rhythm, fluid around the lung, prolonged air leak, wound infection, emergency department visits, or hospital readmission. These problems may not be found early if monitoring is only done during routine vital sign checks or follow-up visits. This study will evaluate whether data collected by a wearable device can help identify early warning signs of postoperative complications in patients undergoing thoracic surgery. The wearable device will collect information such as heart rate, oxygen level, skin temperature, physical activity, sleep, and wearing status. The study includes two parts. First, the researchers will review previously collected wearable device and medical record data to develop an early warning model. Second, new patients undergoing thoracic surgery will wear the device from hospital admission until about 30 days after discharge. The model will then be tested to see how well it predicts complications that require medical intervention within 30 days after surgery. The main goal is to evaluate how accurately the wearable device-based model can identify patients who develop postoperative complications and how early the model can provide a warning before the complication is clinically confirmed.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older. 2. Hospitalized in the Department of Thoracic Surgery of Tongji Hospital and scheduled to undergo thoracic surgery. 3. Able to wear the study-designated wearable device after hospital admission and expected to continue wearing the device and/or uploading data within 30 days after discharge. Exclusion Criteria: 1. Patients or family members are unwilling to wear the wearable device or unable to meet the required wearing time. 2. Severe or unstable psychiatric disease, such as severe depression or schizophrenia. 3. Pregnancy or lactation. 4. Allergy to the watch strap material or local skin conditions that prevent wearing the device. 5. Unable to complete follow-up within 30 days after discharge.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07646730 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07646730 currently recruiting?
Yes, NCT07646730 is actively recruiting participants. Contact the research team at nizhang@tjh.tjmu.edu.cn for enrollment information.
Where is the NCT07646730 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT07646730 clinical trial?
NCT07646730 is sponsored by Tongji Hospital. The trial plans to enroll 650 participants.